Stereotactic radiosurgery for trigeminal neuralgia secondary to vertebrobasilar dolichoectasia: A systematic review and meta-analysis.

Clin Neurol NeurosurgMay 18, 2026 (epub)
Clinical ResearchNeurosurgery

Bardia Hajikarimloo, Salem M Tos, Ibrahim Mohammadzadeh et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis evaluated the efficacy and safety of stereotactic radiosurgery (SRS) for trigeminal neuralgia (TN) secondary to vertebrobasilar dolichoectasia (VBD) in 90 patients. The study found an initial complete pain relief rate of 68% and adequate pain relief in 95% of cases, although pain recurrence occurred in 44% of patients at final follow-up.

Key findings

  • Initial complete pain relief rate was 68% (95% CI: 6%-100%).
  • At final follow-up, complete pain relief was reported in 28% (95% CI: 0%-72%).
  • Pain recurrence occurred in 44% (95% CI: 7%-85%).
  • Transient facial sensory disturbance was 19% (95% CI: 0%-97%).

Why it matters

Understanding the outcomes of SRS for VBD-related TN is crucial for clinicians managing this challenging condition, as it offers a minimally invasive alternative to traditional surgical approaches with varying success rates.

Source

Published in Clin Neurol Neurosurg. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurosurgery

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.